MannKind MannKind is a US-based biopharmaceutical company which has developed the only FDA-cleared inhaled insulin device currently available on the market. On 9 November 2022, the company presented its inhaled insulin device at the 2022 Diabetes Technology Meeting (DTM). MannKind

More Company Profiles

Shanghai Putailai Huayou Recycling Rydberg Technologies Epicore Biosystems Toshiba (Fuel Cell Business) ORF Genetics Coolbrook Jacobi Group: PFAS Treatment in the US Aston Martin Lithium Harvest Shenzhen Dynanonic Fortum (Battery Recycling) Wright Electric: High Energy Density Batteries for Aviation ETH Zurich (Wearable Sweat Sensors) Amazon AWS: Data Centers Ballard Power Systems BNNano: Invicta Water SK tes (Battery Recycling) NIO Vertiv Holdings — Data Center Liquid Cooling Emteq Limited Plug Power Purolite: PFAS Remediation Veolia (Battery Recycling) Universal Matter View more...